February 28, 2022 Pre-Market Earnings Report: XRAY, JLL, FMX, NLSN, TGNA, EYE, WHD, CWEN, DQ, ITRI, HRMY, AUPH


JThe following companies are expected to report earnings before the market opens on 02/28/2022. See our results calendar for a full list of expected results releases.

DENTSPLY SIRONA Inc. (XRAY) reports for the quarter ending Dec. 31, 2021. The medical/dental supplies company’s consensus earnings per share forecast from 9 analysts who track the stock is $0.79. This value represents a decrease of 9.20% compared to the same quarter last year. Over the past year, XRAY has exceeded expectations every quarter. The highest was in the 3rd calendar quarter where they beat consensus by 4.62%. Zacks Investment Research reports that the 2021 price-to-earnings ratio for XRAY is 19.47 versus an industry ratio of 23.30.

Jones Lang LaSalle Incorporated (JLL) reports for the quarter ending Dec. 31, 2021. The real estate company’s consensus earnings per share forecast from the 3 analysts who track the stock is $6.68. This value represents an increase of 26.28% compared to the same quarter last year. Over the past year, JLL has exceeded expectations every quarter. The highest was in the 3rd calendar quarter where they beat consensus by 30.29%. Zacks Investment Research reports that the 2021 price-to-earnings ratio for JLL is 13.52 versus an industry ratio of 15.90.

Fomento Economico Mexicano SAB de CV (FMX) reports for the quarter ending December 31, 2021. The beverage company’s consensus earnings-per-share forecast from the 2 analysts who track the stock is $0.65. This value represents an increase of 482.35% compared to the same quarter last year. FMX missed consensus earnings per share in the 2nd calendar quarter of 2021 by -54.26%. Zacks Investment Research reports that the 2021 price-to-earnings ratio for FMX is 21.94 versus an industry ratio of 7.50, implying that they will have higher earnings growth than their competitors in the same industry.

Nielsen S.A. (NLSN) reports for the quarter ending December 31, 2021. The consensus earnings forecast for the business information services company by the 3 analysts who track the stock is $0.32. This value represents a decrease of 36.00% compared to the same quarter last year. Over the past year, the NLSN has exceeded expectations every quarter. The highest was in the 3rd calendar quarter where they beat consensus by 23.53%. Zacks Investment Research reports that the 2021 price-to-earnings ratio for NLSN is 10.53 versus an industry ratio of 20.50.

TEGNA inc. (TGNA) reports for the quarter ending December 31, 2021. The consensus earnings per share forecast for the broadcasting (radio/television) company from the 2 analysts who track the stock is $0.55. This value represents a decrease of 52.59% compared to the same quarter last year. TGNA missed consensus earnings per share in the 4th calendar quarter of 2020 by -2.52%. Zacks Investment Research reports that the 2021 price-to-earnings ratio for TGNA is 10.63 versus an industry ratio of 3.90, implying that they will have higher earnings growth than their competitors in the same industry.

National Vision Holdings, Inc. (EYE) reports for the quarter ending Dec. 31, 2021. The medical products company’s consensus earnings-per-share forecast from the 3 analysts who track the stock is -$0.06. This value represents a decrease of 113.64% compared to the same quarter last year. Over the past year, EYE has exceeded expectations every quarter. The highest was in the 3rd calendar quarter where they beat consensus by 54.55%. Zacks Investment Research reports that the 2021 price-to-earnings ratio for EYE is 32.42 versus an industry ratio of 5.50, implying that they will have higher earnings growth than their competitors in the same industry.

Cactus, Inc. (WHD) reports for the quarter ending Dec. 31, 2021. The oil company’s consensus earnings-per-share forecast from the 4 analysts who track the stock is $0.20. This value represents an increase of 150.00% compared to the same quarter last year. WHD missed consensus earnings per share in the 2nd calendar quarter of 2021 by -11.11%. Zacks Investment Research reports that the 2021 price-to-earnings ratio for WHD is 72.17 versus an industry ratio of 16.30, implying that they will have higher earnings growth than their competitors in the same industry.

Clearway Energy, Inc. (CWEN) reports for the quarter ending Dec. 31, 2021. The alternative energy company’s consensus earnings per share forecast from 3 analysts who track the stock is $0.05. This value represents a decrease of 54.55% compared to the same quarter last year. Zacks Investment Research reports that the 2021 price-to-earnings ratio for CWEN is 42.51 versus an industry ratio of -23.30, implying that they will have higher earnings growth than their competitors in the same industry.

DAQO New Energy Corp. (DQ) reports for the quarter ending Dec. 31, 2021. The chemical company’s consensus earnings per share forecast from the 1 analyst tracking the stock is $2.34. This value represents an increase of 143.75% compared to the same quarter last year. Zacks Investment Research reports that the 2021 price-to-earnings ratio for DQ is 3.54 versus an industry ratio of 14.20.

Itron, Inc. (ITRI) reports for the quarter ending Dec. 31, 2021. The electrical test equipment company’s consensus earnings per share forecast from 5 analysts who track the stock is $0.22. This value represents a decrease of 66.15% compared to the same quarter last year. ITRI ​​missed consensus earnings per share in the 2nd calendar quarter of 2021 by -44%. Zacks Investment Research reports that the 2021 price-to-earnings ratio for ITRI is 44.96 versus an industry ratio of 29.80, implying that they will have higher earnings growth than their competitors in the same industry.

Harmony Biosciences Holdings, Inc. (HRMY) reports for the quarter ending December 31, 2021. The biomedical company (gene) consensus earnings per share forecast from 4 analysts who track the stock is $0.34. This value represents an increase of 36.00% compared to the same quarter last year. Over the past year, HRMY has exceeded expectations every quarter. The highest was in the 3rd calendar quarter where they beat the consensus of 126.32%. Zacks Investment Research reports that the 2021 price-to-earnings ratio for HRMY is 56.64 versus an industry ratio of -0.90, implying that they will have higher earnings growth than their competitors in the same industry.

Aurinia Pharmaceuticals Inc. (AUPH) reports for the quarter ending December 31, 2021. The pharmaceutical company’s consensus earnings per share forecast from the 4 analysts who track the stock is -$0.26. This value represents a decrease of 420.00% compared to the same quarter last year. Zacks Investment Research reports that the 2021 price-to-earnings ratio for AUPH is -11.25 versus an industry ratio of -1.30.

The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.


nasdaq

Not all news on the site expresses the point of view of the site, but we transmit this news automatically and translate it through programmatic technology on the site and not from a human editor.
Back to top button